Diabetes does not have a single root cause, and the search for one has misled generations of patients and even some clinicians. What we call “diabetes” is actually a family of metabolic diseases that share a common outcome, high blood sugar, but arrive there by different routes. Type 1 diabetes results from immune destruction of insulin-producing cells. Type 2, which accounts for roughly 90 percent of cases worldwide, involves a slow-building collision between genetics, excess fat stored in the wrong organs, chronic inflammation, and a pancreas that gradually loses its ability to compensate. Rarer forms like MODY are driven by single-gene mutations. The honest answer to the title question is that the “real” root cause depends on which type of diabetes you are talking about, and even within type 2, researchers still argue about which domino falls first.
Not One Disease, Several
The first thing that gets lost in popular discussion is that diabetes is an umbrella term. Type 1 diabetes is an autoimmune disease. The immune system attacks the beta cells in the pancreas that make insulin, and once enough are destroyed, a person needs injected insulin to survive. Type 2 diabetes is a metabolic disease in which the body’s tissues stop responding well to insulin, and eventually the pancreas cannot keep up with the demand. LADA (latent autoimmune diabetes in adults) sits somewhere between the two: it looks like type 2 at first but involves the same autoimmune markers seen in type 1. MODY, or maturity-onset diabetes of the young, is caused by mutations in specific genes and accounts for up to about 6 percent of all diabetes cases.1PubMed Central. Differentiating Among Type 1, Type 2 Diabetes, and MODY: Raising Awareness About the Clinical Implementation of Genetic Testing in Latin America Autoimmune markers and a test measuring C-peptide, which reflects how much insulin the pancreas is still making, are the main tools clinicians use to sort one type from another.2PubMed. Clinical, biochemical and immunological characteristic of diabetes type I, LADA, diabetes type II, and MODY patients
This distinction matters because the root cause of each type is genuinely different. A person with type 1 needs strategies that address autoimmunity. A person with MODY has a genetic defect in one of the enzymes or transcription factors involved in insulin production, and certain MODY subtypes respond to specific oral medications rather than insulin. Lumping all of these under a single “root cause” does real harm: it leads people with autoimmune diabetes to think they brought the disease on themselves through diet, and it leads people with type 2 to misunderstand the biological machinery that is actually breaking down.
The Chicken-and-Egg Problem in Type 2
For decades, the textbook story of type 2 diabetes went like this: excess body weight leads to insulin resistance, the pancreas compensates by pumping out more insulin, and eventually the beta cells burn out. That story is not wrong, but it increasingly looks incomplete, and the order of events may be partially reversed. A competing hypothesis argues that the real starting point is chronic overproduction of insulin itself, and that insulin resistance is the body’s protective response to being flooded with too much of the hormone.3PubMed Central. Pathophysiology of Prediabetes Hyperinsulinemia and Insulin Resistance in the Cardiovascular System Barbara Corkey, a prominent metabolism researcher, proposed that environmental agents cause redox disturbances in beta cells, leading them to secrete excess insulin even before insulin resistance sets in.4National Medical Journal of China. Hyperinsulinemia: cause or consequence
This debate is not just academic hair-splitting. If insulin resistance comes first, then the main therapeutic target is making tissues more sensitive to insulin through exercise, weight loss, and medications like metformin. If hyperinsulinemia comes first, then the priority shifts to whatever is driving the pancreas to over-secrete, whether that is certain foods, environmental chemicals, or something else. In practice, both pathways probably operate simultaneously, reinforcing each other in a vicious cycle. But the question of which comes first shapes how aggressively clinicians target insulin levels versus insulin sensitivity, and it influences dietary advice at the prediabetes stage.
Fat in the Wrong Places
One of the most compelling frameworks for understanding type 2 diabetes over the past fifteen years is the Twin Cycle Hypothesis, developed by Roy Taylor and colleagues. The core idea is that chronic excess calorie intake leads to fat accumulation not just under the skin but inside the liver and the pancreas, and that this ectopic fat is what drives the disease.5PubMed Central. Pathogenesis and remission of type 2 diabetes: what has the twin cycle hypothesis taught us?
The mechanism works roughly like this. Fat in the liver makes it resistant to insulin’s normal signal to stop releasing glucose into the blood. As fasting blood glucose drifts upward, the pancreas responds by making more insulin, and that extra insulin actually drives even more fat production in the liver, creating the first vicious cycle. Meanwhile, the fatty liver exports more triglyceride-rich particles into the bloodstream, and some of that fat gets deposited in the pancreatic islets, the clusters of cells that produce insulin. Fat buildup in the islets impairs their ability to secrete insulin properly in response to meals, creating a second vicious cycle that eventually tips fasting and post-meal glucose into the diabetic range.6PubMed Central. The Twin Cycle Hypothesis of type 2 diabetes aetiology: From concept to national NHS programme
What makes this framework especially powerful is that it explains why substantial weight loss can put type 2 diabetes into remission. If you drain the fat out of the liver and pancreas, the twin cycles reverse. This has been confirmed in clinical trials and now underpins national health programs in the UK. It also explains why some people develop diabetes at a relatively lean body weight: what matters is not total body fat, but how much fat has accumulated in these two critical organs, and that threshold varies from person to person.
Inflammation as an Accelerant
Excess fat tissue is not just inert storage. Fat cells, especially the kind packed around internal organs, become inflamed and attract immune cells called macrophages. In people with obesity, these macrophages release inflammatory molecules such as tumor necrosis factor-alpha (TNF-α) and C-reactive protein (CRP), both of which are associated with reduced insulin sensitivity and reduced muscle oxidative capacity.7PubMed Central. Adipose tissue macrophage populations and inflammation are associated with systemic inflammation and insulin resistance in obesity In other words, inflamed fat tissue does not just sit there; it actively poisons the metabolic environment by broadcasting signals that make muscles and the liver less responsive to insulin.
At a cellular level, one of the ways this damage gets transmitted involves fat-derived molecules called ceramides. When ceramide levels rise inside muscle cells, they interfere with the signaling chain that normally tells the cell to absorb glucose in response to insulin.8Frontiers in Endocrinology. The Role of Ceramides in Insulin Resistance Ceramides essentially jam the lock on the insulin receptor’s downstream pathway, so even when insulin is present, the cell does not respond properly. This is part of why exercise is so effective at improving insulin sensitivity: contracting muscles burn through intracellular lipids and reduce ceramide accumulation.
When the Pancreas Loses Its Identity
For a long time, researchers assumed that beta cells in type 2 diabetes simply died off. More recent work has revealed something stranger: many beta cells do not die. Instead, they lose their specialized identity and revert to a less mature, progenitor-like state, a process called dedifferentiation. These dedifferentiated cells stop expressing the genes they need to sense glucose and secrete insulin properly.9PubMed Central. Editorial: Pancreatic beta-cell dedifferentiation The metabolic stresses that drive this include prolonged exposure to high glucose and high fat, along with stress on the cell’s internal protein-folding machinery.
This finding matters because dedifferentiation is at least partially reversible. If you remove the metabolic insult, whether by weight loss, bariatric surgery, or intensive blood sugar management, some of these cells can regain their function. That aligns with clinical observations that people who achieve diabetes remission early in the disease have a much better chance of restoring normal insulin secretion than people who wait years. The longer beta cells spend in a dedifferentiated state, the harder it is to coax them back.
Genetics Load the Gun
No discussion of root causes is complete without genetics, but the way genes contribute to diabetes is often misunderstood. For type 2 diabetes, there is no single “diabetes gene.” Instead, dozens of common genetic variants each contribute a small amount of risk. The strongest of these involves the gene TCF7L2. People who carry two copies of the risk variant at this gene have roughly a 55 percent higher chance of progressing from prediabetes to diabetes over a three-year period compared to those without it, and the effect works through impaired insulin secretion rather than increased insulin resistance.10PubMed Central. TCF7L2 polymorphisms and progression to diabetes in the Diabetes Prevention Program Expression of TCF7L2 in the pancreatic islets of people with type 2 diabetes is about five-fold higher than normal, and overexpression of the gene actually reduces insulin secretion in response to glucose.11Journal of Clinical Investigation. Prime suspect: the TCF7L2 gene and type 2 diabetes risk
For type 1 diabetes, the genetic picture is dominated by the HLA region of the genome, which encodes proteins central to immune recognition. Specific variants in genes encoding the HLA-DQ and HLA-DR molecules are the strongest genetic predictors of type 1 risk.12PubMed Central. Genetics of the HLA region in the prediction of type 1 diabetes These variants affect how the immune system presents fragments of proteins to T cells, and certain combinations make it more likely that the immune system will mistakenly target beta-cell proteins as foreign invaders. But genetics alone is not destiny: identical twins share all their DNA, yet when one twin develops type 1 diabetes, the other develops it only about 30 to 50 percent of the time. Something environmental has to pull the trigger.
Viral Triggers and Type 1 Diabetes
The environmental trigger that has accumulated the strongest evidence in type 1 diabetes is infection with enteroviruses, particularly coxsackievirus B. Prospective studies have linked persistent enteroviral infection with the appearance of the autoantibodies that precede type 1 diabetes, and the virus has been found in pancreatic tissue of people with the disease.13Nature Reviews Endocrinology. Persistent coxsackievirus B infection and pathogenesis of type 1 diabetes mellitus The virus can persist in pancreatic ductal and beta cells, leading to structural changes in those cells and chronic inflammation that attracts and activates immune cells already primed to attack. One proposed mechanism is molecular mimicry: parts of the virus look similar enough to beta-cell proteins that the immune response originally aimed at the virus spills over into an autoimmune attack on the pancreas.14PubMed. Coxsackievirus and Type 1 Diabetes: Diabetogenic Mechanisms and Implications for Prevention
This connection has practical implications. Researchers are actively developing enterovirus vaccines aimed at preventing or delaying type 1 diabetes in genetically susceptible children.15PubMed Central. Fighting Enteroviral Infections to Prevent Type 1 Diabetes If successful, such a vaccine would be the first intervention to address a root cause of type 1 diabetes rather than managing the consequences after the fact.
Fructose, Sleep, and the Modern Environment
For type 2 diabetes, several features of modern life appear to interact with genetic susceptibility in ways that push people toward the disease. Dietary fructose, consumed in large amounts through sweetened beverages and processed foods, deserves particular attention. Unlike glucose, fructose is metabolized almost entirely by the liver, where it drives new fat production, impairs fat burning, triggers internal cell stress, and promotes inflammation, all of which contribute to hepatic insulin resistance.16PubMed Central. Fructose and hepatic insulin resistance High fructose intake also ramps up triglyceride production, feeding directly into the twin-cycle mechanism described earlier.17PubMed Central. Fructose, insulin resistance, and metabolic dyslipidemia
Disrupted sleep and circadian rhythms are another underappreciated contributor. Your body’s internal clocks regulate insulin secretion from the pancreas, glucose absorption in the gut, and insulin sensitivity in muscle, fat, and liver tissue. When these clocks are thrown off by shift work, irregular sleep schedules, or exposure to artificial light at night, glucose control suffers.18PubMed. Circadian clocks and insulin resistance Sleep restriction combined with circadian disruption raises blood glucose levels in humans, and animal models show that circadian disruption accelerates beta-cell loss and dysfunction.19Frontiers in Endocrinology. Circadian rhythms and pancreas physiology: A review Shift workers have consistently higher rates of type 2 diabetes, and this risk is not fully explained by other lifestyle factors like diet or exercise.
Then there is the growing evidence around endocrine-disrupting chemicals: synthetic compounds found in plastics, pesticides, food packaging, and countless consumer products. A wide range of these chemicals have been shown to alter insulin secretion, insulin action, and overall glucose balance in cell studies, animal models, and human population data.20PubMed Central. Inappropriately sweet: Environmental endocrine-disrupting chemicals and the diabetes pandemic The individual effect of any one chemical may be small, but we are exposed to many of them simultaneously, and their combined impact on metabolic health is something researchers are still working to quantify.
The Gut Microbiome Connection
Your intestinal bacteria influence diabetes risk in ways that would have sounded far-fetched twenty years ago. High-fat diets and obesity alter the composition of the gut microbiome, increasing intestinal permeability, sometimes called “leaky gut.” When the gut lining becomes more permeable, fragments of bacterial cell walls, particularly a molecule called lipopolysaccharide (LPS), leak into the bloodstream. LPS activates immune receptors and triggers low-grade inflammation throughout the body, contributing to insulin resistance.21PubMed Central. The Gut Microbiota–Insulin Resistance Axis: Mechanisms, Clinical Implications, and Therapeutic Potential
Animal experiments have shown that the metabolic damage caused by high-fat feeding, including glucose intolerance, insulin resistance, and systemic inflammation, can be partially or completely blocked by giving antibiotics that reshape the gut microbiome or by genetically removing the receptor that recognizes LPS.22The Journal of Clinical Endocrinology & Metabolism. Mechanisms Linking the Gut Microbiome and Glucose Metabolism That does not mean antibiotics are a treatment for diabetes; the point is that gut bacteria are not innocent bystanders. They actively participate in the metabolic cascade that leads to insulin resistance. Human clinical trials exploring fecal microbiota transplants and targeted probiotics are underway, though we are still far from translating this into reliable therapy.
Why Some People Get Diabetes at a Normal Weight
A persistent misconception is that diabetes is purely a disease of overweight people. While excess body fat is the strongest modifiable risk factor for type 2, somewhere between 10 and 15 percent of people diagnosed with it are not overweight by standard measures. Part of the explanation lies in the ectopic fat concept: these individuals may carry more fat inside the liver and pancreas than their outward appearance suggests. Part lies in genetics: variants like those in TCF7L2 impair beta-cell function regardless of body weight.11Journal of Clinical Investigation. Prime suspect: the TCF7L2 gene and type 2 diabetes risk And part may trace back to conditions before birth. The Barker hypothesis proposes that poor nutrition during fetal development programs the body for metabolic disease later in life, and low birth weight is now considered a risk indicator for diabetes, heart disease, and other conditions in adulthood.23PubMed Central. The fascinating theory of fetal programming of adult diseases: A review of the fundamentals of the Barker hypothesis
There is also evidence that the small blood vessels feeding metabolically active tissues play a role. Endothelial dysfunction, where the lining of blood vessels does not work properly, can impair insulin delivery to muscle and fat tissue. If insulin cannot physically reach the cells it needs to act on because the capillary network is not expanding properly, those tissues behave as though they are insulin resistant even when the molecular signaling inside the cells is intact.24PubMed. Insulin resistance and endothelial dysfunction: the road map to cardiovascular diseases This vascular dimension of insulin resistance helps explain why cardiovascular disease and diabetes are so tightly linked: they share the same damaged plumbing.
The Incretin System and Why It Fades
If you have followed the explosion of GLP-1 medications like semaglutide, you have heard about incretins without necessarily understanding why they matter to the root cause question. Incretins are gut hormones released when you eat; they amplify the insulin response so that eating food triggers far more insulin than an equivalent amount of glucose injected into a vein would. In people with type 2 diabetes, this amplification effect is blunted. GLP-1 still works reasonably well, but GIP, the other major incretin, loses much of its ability to stimulate insulin secretion, and researchers still do not fully understand why.25PubMed. The evolving story of incretins (GIP and GLP-1) in metabolic and cardiovascular disease: A pathophysiological update
This impaired incretin effect is not just a symptom of diabetes; it appears early, in the prediabetic stage, suggesting it plays a causal role. The success of GLP-1 receptor agonists in lowering blood sugar, reducing appetite, and driving weight loss speaks to how central this hormonal axis is to the metabolic network that goes wrong in type 2. It also underscores the point that diabetes is not just about one organ or one molecule. The gut, the pancreas, the liver, the brain, fat tissue, muscle, and the blood vessels connecting them all participate, and the disease emerges when enough of these systems fail simultaneously.
Mitochondria and the Cellular Energy Crisis
Beneath all the organ-level dysfunction sits a fundamental problem with cellular energy production. Mitochondria, the structures inside cells that convert nutrients into usable energy, appear to work less efficiently in people with insulin resistance. When mitochondria are sluggish, they produce more damaging byproducts called reactive oxygen species while generating less energy per unit of fuel. This oxidative stress, compounded by aging, genetic factors, and reduced production of new mitochondria, has been proposed as a central contributor to insulin resistance across multiple tissues.26PubMed. Role of mitochondrial dysfunction in insulin resistance Whether mitochondrial dysfunction is a cause or a consequence of excess fat and inflammation is still debated, but it adds another layer to the picture: even at the level of individual cells, the energy machinery is compromised in ways that make insulin resistance self-reinforcing.